recombinant parainfluenza virus vector vaccine (University of Iowa/University of Georgia)

N/A

Report date: 2025/01/26 17:44:09

Base Information

Drug Namerecombinant parainfluenza virus vector vaccine (University of Iowa/University of Georgia)

Drug Alias NameMERS vaccine (recombinant parainfluenza virus vector) (University of Iowa/University of Georgia)PIV5-MERS-S

ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesThe University Of Iowa

China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Iowa University Of Georgia

Inactive CompaniesN/A

Active IndicationsCoronavirus Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A